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Analysis of Relapse in Leukemia Patients With Missing Data Using 
the EM-Algorithm
Braydon Schaible, MPH, Lili Yu, PhD
Biostatistics
RESULTS INTRODUCTION
1. Leukemia is a type of cancer. In 2014, over 18,000 people were diagnosed 
with AML and approximately 6,000 people were diagnosed with ALL 
(Leukemia & Lymphoma Society, 2015). The overall survival rates over a 5 
year period for patients diagnosed with ALL is 70% and 25.4% for patients 
diagnosed with AML (Leukemia & Lymphoma Society, 2015). Relapse rates 
for AML vary from 33% to 78% depending on the patients risk classification 
(good, intermediate, poor) (Grimwade et al, 1998). For children originally 
diagnosed with ALL who have achieved complete remission, there is a 15%-
20% chance of relapse (Dana-Farber Boston Children’s, 2015).
2. Leukemia has high relapse rates, which will reduce the overall survival time 
for patients and lower their quality of life. Therefore, it is important to do 
research on the relapse of the Leukemia patients.
3. We will analyze a dataset that includes information for 137 bone marrow 
transplant patients with leukemia. From the statistical analysis we will find 
significant factors that can affect the relapse, in order to find ways for 
clinicians to make better treatment plans.
METHODS 
1. We use the Expectation-Maximization (EM) algorithm. In the expectation 
step, we use the mean predicted probability as the cut-point to impute the 
missing binary response variable. In the maximization step, we use logistic 
regression to find the parameter estimates of the coefficients and then the 
significant factors.  There are three steps to the EM logistic regression model. 
(1) The first step, the initial step, requires us to obtain initial parameter values. 
These values are obtained by running a logistic regression model, using only 
the observations where there is no missing data, containing all variables of 
possible interest. 
(2) Next, the probability of relapse is calculated, based on the model obtained in 
the initial step, for all observations (including those with missing relapse 
indicator variable). Then, based on the cut-point determined by calculating the 
mean of the predicted probabilities, the data for the observations with missing 
relapse indicator variable are imputed in the expectation step. 
(3) If the probability of relapse is greater than the specified cut-point, then the 
imputed value is 1 (relapse), otherwise the imputed value is 0 (no relapse). A 
logistic regression is then run on the imputed data which returns a set of 
parameter values which are then used in the next iteration of the algorithm (this 
is the maximization step) (Anderson & Hardin, 2014). The algorithm iterates 
between step (2) and step (3) until the parameter values converge.
2. We do model selection to select the significant factors that can affect the 
relapse of Leukemia patients. We use backward elimination to delete non-
significant factors one by one.
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CONCLUSIONS 
This study used the EM algorithm, along with selecting the cut-point based on 
the mean of the predicted probabilities at each iteration, to impute missing data 
for the relapse indicator variable. Based on the final model, it was found that the 
variables Z4 (Donor Sex: 1-Male, 0-Female), Z5 (Patient CMV Status: 1-CMV 
Positive, 0-CMV Negative), and Z8 (FAB Grade: 1-FAB Grade 4 or 5 & AML, 0-
Otherwise) are significant factors when predicting leukemia relapse. This 
method can be applied to many other studies on diseases other than leukemia 
as long as the missing data mechanism is MAR.
STRENGTHS & LIMITATIONS
Limitations:
Data was not collected regarding the type of leukemia (AML vs ALL), it is only 
known that the data contains information from patients diagnosed with AML or 
ALL. There are very different relapse rates for the two types of acute leukemia 
and this is not taken into account.
The method used was only applied to those patients diagnosed with AML or 
ALL that had already received a bone marrow transplant.
The method is applicable only to datasets where the missing data mechanism 
is missing at random (MAR) and the missing data is in a categorical response 
variable.
The sample size is small.
Strengths:
This method adds to an already successful method applied by Anderson and 
Hardin (Anderson & Hardin, 2014) by selecting an optimal cut point at each 
iteration, rather than using the same cut point throughout the process.
The method used in this study incorporates the use of a likelihood method for 
imputation of missing data where the missing data mechanism is MAR.
This method showed faster convergence than using just the EM algorithm 
alone on this specific dataset (4 iterations for this method compared to 5 
iterations using the same cut point at each iteration).
PURPOSE
The purpose of this study was to find significant factors that can affect  the 
relapse of Leukemia patients. The dataset contained 54 observations which had 
missing response variable (relapse variable) data. Therefore, we propose a new 
statistical methodology to impute the missing binary response variable, in which 
we assume the missing data mechanism for this dataset is assumed to be 
missing at random (MAR). 
PUBLIC HEALTH SIGNIFICANCE
This is a new, original method that can be extended to analyzing other 
disease datasets where there are missing data for a categorical response 
variable and the missing data mechanism is assumed to be MAR.
In this case, it was found that Donor Sex, Patient CMV Status, and FAB 
Grade together create a significant model for predicting relapse in leukemia 
patients with AML or ALL.
Knowing about the significant predictors of leukemia relapse, medical 
professionals can create better, more knowledgeable treatment plans for 
different patients.
The results of this study can be used to develop health education programs 
and interventions targeting physicians to increase their awareness of the 
possible factors affecting leukemia relapse.
Policy officials should be aware of some of the possible factors contributing 
towards leukemia relapse and construct their policies accordingly.
Leukemia Relapse EM-Algorithm Parameter Estimates – Model Containing All Independent Variables
Iteration Intercept Z1 Z2 Z3 Z4 Z5 Z6 Z7 Z8 Z10 Cut Point
Initial Estimates -0.1468 -0.0046 -0.0129 -0.2509 0.3626 0.6262 0.0371 -0.0004 0.8024 0.069 N/A
1 -0.8481 0.0079 -0.0334 -0.2243 0.8747 1.3752 -0.0691 -0.001 1.5843 0.1185 0.4845
2 -1.0739 0.0242 -0.0426 -0.1596 0.9302 1.4069 -0.01198 -0.001 1.5266 0.0067 0.4599
3 -1.2335 0.0267 -0.0469 -0.0686 1.0346 1.4674 0.0357 -0.0009 1.4358 0.0222 0.4672
4 -1.2335 0.0267 -0.0469 -0.0686 1.0346 1.4674 0.0357 -0.0009 1.4358 0.0222 0.4599
Analysis of Maximum Likelihood Estimates – Model Containing All 
Independent Variables
Parameter DF Estimate Standard 
Error
P-Value
Intercept 1 -1.2335 0.8142 0.129781
Z1 1 0.0267 0.0329 0.416916
Z2 1 -0.0469 0.0305 0.123748
Z3 1 -0.0686 0.4201 0.870345
Z4 1 1.0346 0.4324 0.016726
Z5 1 1.4674 0.4599 0.001418
Z6 1 0.0357 0.4424 0.935747
Z7 1 -0.0009 0.0008 0.238047
Z8 1 1.4358 0.4454 0.001267
Z10 1 0.0222 0.4802 0.963084
Model: Relapse=int + Z4 + Z5 + Z8
Analysis of Maximum Likelihood Estimates
Parameter DF Estimate Standard Error P-Value
Intercept
1 -2.114 0.4591 4.14E-06
Z4
1 1.1285 0.4229 0.00762
Z5
1 1.4661 0.4003 0.00025
Z8
1 1.5257 0.4332 0.000429
Iteration Intercept Z4 Z5 Z8 Cut Point
Initial Estimates -0.875 0.3796 0.5808 0.8528 N/A
1 -1.9965 1.0190 1.3956 1.6251 0.484453
2 -2.114 1.1285 1.4661 1.5257 0.4744526
3 -2.114 1.1285 1.4661 1.5257 0.4671533
Results from the EM algorithm for full model
Results from model selection
